Abstract
As a core challenge in the field of rheumatology and immunology, difficult-to-treat rheumatoid arthritis (D2T-RA) remains a focal point of both clinical and basic research. Although a globally unified definition has yet to be established, the criteria set forth by the European Alliance of Associations for Rheumatology (EULAR) are currently the primary reference. It is now widely accepted that D2T-RA represents a state of persistent inflammation driven by a confluence of multiple factors. This review systematically summarizes the mechanisms of resistance to methotrexate, biologics, and targeted small-molecule drugs, alongside potential pathogenetic mechanisms underlying D2T-RA. Building on this foundation, we discuss clinical strategies for managing resistance—ranging from traditional disease-modifying antirheumatic drugs (DMARDs) to biologics and targeted therapies—and explore future directions in the field. Ultimately, this review aims to provide a viable and promising research framework for the treatment of difficult-to-treat rheumatoid arthritis.
Full text
6,149 characters
· extracted from
preprint-html
· click to expand
Research progress on drug resistance mechanisms and therapeutic strategies for difficult-to-treat rheumatoid arthritis | Authorea try { document.documentElement.classList.add('js'); } catch (e) { } var _gaq = _gaq || []; _gaq.push(['_setAccount', 'G-8VDV14Y67G']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); Skip to main content Preprints Collections Wiley Open Research IET Open Research Ecological Society of Japan All Collections About About Authorea FAQs Contact Us Quick Search anywhere Search for preprint articles, keywords, etc. Search Search ADVANCED SEARCH SCROLL British Journal of Pharmacology This is a preprint and has not been peer reviewed. Data may be preliminary. 12 May 2026 V1 Latest version Share on Research progress on drug resistance mechanisms and therapeutic strategies for difficult-to-treat rheumatoid arthritis Authors : Xinling Ge [email protected] , Wei Wei 0000-0002-3117-9598 [email protected] , and Yu-Jing Wu 0000-0003-1600-0024 [email protected] Authors Info & Affiliations https://doi.org/10.22541/authorea.15003150/v1 14 views 5 downloads Contents Abstract Graphical Abstract Information & Authors Metrics & Citations View Options References Figures Tables Media Share Abstract As a core challenge in the field of rheumatology and immunology, difficult-to-treat rheumatoid arthritis (D2T-RA) remains a focal point of both clinical and basic research. Although a globally unified definition has yet to be established, the criteria set forth by the European Alliance of Associations for Rheumatology (EULAR) are currently the primary reference. It is now widely accepted that D2T-RA represents a state of persistent inflammation driven by a confluence of multiple factors. This review systematically summarizes the mechanisms of resistance to methotrexate, biologics, and targeted small-molecule drugs, alongside potential pathogenetic mechanisms underlying D2T-RA. Building on this foundation, we discuss clinical strategies for managing resistance—ranging from traditional disease-modifying antirheumatic drugs (DMARDs) to biologics and targeted therapies—and explore future directions in the field. Ultimately, this review aims to provide a viable and promising research framework for the treatment of difficult-to-treat rheumatoid arthritis. Graphical Abstract Information & Authors Information Version history V1 Version 1 12 May 2026 Collection British Journal of Pharmacology Authors Affiliations Xinling Ge [email protected] View all articles by this author Wei Wei 0000-0002-3117-9598 [email protected] View all articles by this author Yu-Jing Wu 0000-0003-1600-0024 [email protected] View all articles by this author Metrics & Citations Metrics Article Usage 14 views 5 downloads .FvxKWukQNSOunydq8rnd { width: 100px; } Citations Download citation Xinling Ge, Wei Wei, Yu-Jing Wu. Research progress on drug resistance mechanisms and therapeutic strategies for difficult-to-treat rheumatoid arthritis. Authorea . 12 May 2026. DOI: https://doi.org/10.22541/authorea.15003150/v1 If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see 'Downloading to a citation manager' in the Help menu . Format Please select one from the list RIS (ProCite, Reference Manager) EndNote BibTex Medlars RefWorks Direct import Tips for downloading citations document.getElementById('citMgrHelpLink').addEventListener('click', function() { popupHelp(this.href); return false; }); $(".js__slcInclude").on("change", function(e){ if ($(this).val() == 'refworks') $('#direct').prop("checked", false); $('#direct').prop("disabled", ($(this).val() == 'refworks')); }); View Options View options PDF View PDF Figures Tables Media Share Share Share article link Copy Link Copied! Copying failed. Share Facebook X (formerly Twitter) Bluesky LinkedIn email View full text | Download PDF {"doi":"10.22541/authorea.15003150/v1","type":"Article"} Now Reading: Share Figures Tables Close figure viewer Back to article Figure title goes here Change zoom level Go to figure location within the article Download figure Toggle share panel Toggle share panel Share Toggle information panel Toggle information panel Go to previous graphic Go to next graphic Go to previous table Go to next table All figures All tables View all material View all material xrefBack.goTo xrefBack.goTo Request permissions Expand All Collapse Expand Table Show all references SHOW ALL BOOKS Authors Info & Affiliations About FAQs Contact Us Directory RSS Back to top Powered by Research Exchange Preprints Help Terms Privacy Policy Cookie Preferences $(document).ready(() => setTimeout(() => { let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" ")); $.get("/resource/lodash?t="+_bnt); },4000)); (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9fe36b400f431b23',t:'MTc3OTE5NzAzNQ=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.